SCHEMBL4108336

SCHEMBL4108336

CC(C)([NH])CC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL95498 0.78
SCHEMBL1140241 0.75
T-Butylacetic Acid SCHEMBL71379 0.73
SCHEMBL48109 0.73 KDM4E (0.65)
T-Butylacetic Acid SCHEMBL10950588 0.73 HMGCR (0.61)
SCHEMBL30854909 0.73 KDM4E (0.65)
SCHEMBL544642 0.73 HMGCR (0.61)
SCHEMBL7252624 0.73 HMGCR (0.61)
T-Butylacetic Acid SCHEMBL973430 0.71
SCHEMBL6733907 0.71 KDM4E (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431565-B2 Substituted imidazoheterocycles CARA THERAPEUTICS, INC. (US) 2013-04-30 US claimed
US-20090149450-A1 SUBSTITUTED IMIDAZOHETEROCYCLES CARA THERAPEUTICS, INC. (US) 2009-06-11 US claimed